Product
Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA)
1 clinical trial
1 indication
Indication
Superficial Basal Cell CarcinomaClinical trial
A Randomized, Double Blind, Vehicle-controlled Multicenter Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).Status: Active (not recruiting), Estimated PCD: 2024-03-19